Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | NOTE 10 EMPLOYEE STOCK OPTIONS AND RESTRICTED STOCK AWARD PLAN In 2011, the Company’s Board of Directors approved and adopted a long term incentive plan, which was subsequently approved and amended by the shareholders. There were 1,040,200 Grant date # of options Exercise price April 1, 2015 3,750 $ 10.89 December 9, 2015 291,000 8.25 January 13, 2016 (1) 241,000 $ 5.25 May 3, 2016 15,000 6.42 December 13, 2016 582,500 11.75 April 20, 2017 7,500 $ 11.70 1,140,750 (1) On December 9, 2015, Ring issued option awards to its named executive officers and directors. On January 13, 2016, upon the recommendation of the Compensation Committee, Ring rescinded the option awards granted to its employees and directors (other than Messrs. McCabe and Rochford, who are the members of the Compensation Committee) as the result of a significant decline in the stock price and re-issued the option awards as of that date to meet the goals and objectives of the Company’s equity based compensation program. The amounts shown as Option Awards include the additional fair value of the new options over the original grant. All granted options vest at the rate of 20 2017 2016 2015 Weighted- Weighted- Weighted- Average Average Average Options Exercise Price Options Exercise Price Options Exercise Price Outstanding at beginning of the year 3,362,350 $ 5.90 2,881,750 $ 5.07 2,684,500 $ 4.67 Issued 7,500 11.70 838,500 9.79 294,750 8.28 Forfeited or rescinded (11,450) 10.12 (331,400) 8.62 (32,500) 4.47 Exercised (165,400) 2.63 (26,500) 4.41 (65,000) 3.46 Outstanding at end of year 3,193,000 $ 6.07 3,362,350 $ 5.90 2,881,750 $ 5.07 Exercisable at end of year 2,091,900 $ 4.85 1,722,850 $ 4.01 1,214,000 $ 3.85 Weighted average fair value of options granted during the year $ 9.14 $ 9.72 $ 6.55 The Company uses the Black-Scholes option pricing model to calculate the fair-value of each option grant. The expected volatility is based on the historical price volatility of the Company’s common stock. We elected to use the simplified method for estimating the expected term as allowed by generally accepted accounting principles for options granted during the years ended December 31, 2017, 2016 and 2015. Under the simplified method, the expected term is equal to the midpoint between the vesting period and the contractual term of the stock option. The risk-free interest rate represents the U.S. Treasury bill rate for the expected life of the related stock options. The dividend yield represents the Company’s anticipated cash dividend over the expected life of the stock options. Risk free interest rate Expected life (years) Dividend yield Volatility April 1, 2015 1.32 % 6.5 - 103 % December 9, 2015 1.64 % 6.5 - 100 % January 13, 2016 1.51 % 6.5 - 100 % May 3, 2016 1.25 % 6.5 - 99 % December 13, 2016 1.92 % 6.5 - 96 % April 20, 2017 1.78 % 6.5 - 94 % For the years ended December 31, 2017, 2016 and 2015, the Company incurred stock based compensation expense related to stock options of $ 3,618,309 2,267,053 2,566,716 3,741,997 2.5 25,126,363 19,884,600 13.90 Options exercised of 165,400 26,500 65,000 1,744,047 65,089 476,642 The following table summarizes information related to the Company’s stock options outstanding at December 31, 2017: Options Outstanding Exercise price Number Weighted- Number 2.00 555,000 4.17 555,000 4.50 1,340,000 5.24 1,080,000 5.50 5,000 5.45 - 7.50 29,000 5.73 23,000 10.00 90,000 6.21 72,000 14.54 20,000 6.99 12,000 8.00 282,500 7.17 168,700 8.25 50,000 8.19 20,000 5.25 223,000 8.28 45,000 6.42 15,000 8.59 3,000 11.75 576,000 9.20 115,200 11.70 7,500 9.30 - 3,193,000 6.27 2,093,900 Any excess tax benefits from the exercise of stock options will not be recognized in paid-in capital until the Company is in a current tax paying position. Presently, the company has a net loss and therefore not yet subject to income taxes. Accordingly, no excess tax benefits have been recognized for the years ended December 31, 2017, 2016 or 2015. Grant date # of shares of December 19, 2017 330,900 All restricted stock grants vest at the rate of 20 2017 Restricted stock Weighted- Outstanding at beginning of the year - $ - Granted 330,900 13.44 Forfeited or rescinded - - Vested - - Outstanding at end of year 330,900 $ 13.44 No restricted stock was granted prior to 2017. No restricted stock vested during 2017. For the year ended December 31, 2017, the Company incurred stock based compensation expense related to restricted stock grants of $ 66,770 4,380,526 2.0 |